Porton Down, UK, 3 December 2010: GW Pharmaceuticals (AIM: GWP) today announces that it has appointed Peel Hunt Limited as Nominated Adviser and broker to the Company with immediate effect.
The Company also provides notification in accordance with the AIM Rules that Mr James Noble, a non-executive director of the Company, was previously a Director of Axellis Limited (“Axellis”) which entered into a creditors’ voluntary liquidation on 26 July 2010.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt Limited (Nominated Adviser) +44 (0) 20 7418 8900
Financial Dynamics + 44 (0) 20 7831 3113
Ben Atwell / John Dineen